116 related articles for article (PubMed ID: 38436253)
21. Photothermal MnO
Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
[TBL] [Abstract][Full Text] [Related]
22. Laser-Induced Combinatorial Chemotherapeutic, Chemodynamic, and Photothermal Therapy for Hepatocellular Carcinoma Based on Oxaliplatin-Loaded Metal-Organic Frameworks.
Huang R; Liu W; Zhang Q; Zhu G; Qu W; Tao C; Gao J; Fang Y; Fu X; Zhou J; Shi Y; Fan J; Tang Z
ACS Appl Mater Interfaces; 2023 Jan; 15(3):3781-3790. PubMed ID: 36631295
[TBL] [Abstract][Full Text] [Related]
23. Folic Acid-Modified Erythrocyte Membrane Loading Dual Drug for Targeted and Chemo-Photothermal Synergistic Cancer Therapy.
Chen Z; Wang W; Li Y; Wei C; Zhong P; He D; Liu H; Wang P; Huang Z; Zhu W; Zhou Y; Qin L
Mol Pharm; 2021 Jan; 18(1):386-402. PubMed ID: 33296217
[TBL] [Abstract][Full Text] [Related]
24. Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases.
Yang J; Su H; Sun W; Cai J; Liu S; Chai Y; Zhang C
Theranostics; 2018; 8(7):1966-1984. PubMed ID: 29556368
[TBL] [Abstract][Full Text] [Related]
25. Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer.
Wang M; Li Y; Wang M; Liu K; Hoover AR; Li M; Towner RA; Mukherjee P; Zhou F; Qu J; Chen WR
Acta Biomater; 2022 Jan; 138():453-462. PubMed ID: 34757232
[TBL] [Abstract][Full Text] [Related]
26. IR792-MCN@ZIF-8-PD-L1 siRNA drug delivery system enhances photothermal immunotherapy for triple-negative breast cancer under near-infrared laser irradiation.
Wang Y; Wang H; Song Y; Lv M; Mao Y; Song H; Wang Y; Nie G; Liu X; Cui J; Zou X
J Nanobiotechnology; 2022 Mar; 20(1):96. PubMed ID: 35236356
[TBL] [Abstract][Full Text] [Related]
27. Induction of immunogenic cell death of cancer cells through nanoparticle-mediated dual chemotherapy and photothermal therapy.
Heshmati Aghda N; Abdulsahib SM; Severson C; Lara EJ; Torres Hurtado S; Yildiz T; Castillo JA; Tunnell JW; Betancourt T
Int J Pharm; 2020 Nov; 589():119787. PubMed ID: 32898630
[TBL] [Abstract][Full Text] [Related]
28. An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy.
Li L; Yang S; Song L; Zeng Y; He T; Wang N; Yu C; Yin T; Liu L; Wei X; Wu Q; Wei Y; Yang L; Gong C
Theranostics; 2018; 8(3):860-873. PubMed ID: 29344312
[TBL] [Abstract][Full Text] [Related]
29. Autophagy inhibition enabled efficient photothermal therapy at a mild temperature.
Zhou Z; Yan Y; Hu K; Zou Y; Li Y; Ma R; Zhang Q; Cheng Y
Biomaterials; 2017 Oct; 141():116-124. PubMed ID: 28675807
[TBL] [Abstract][Full Text] [Related]
30. Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
Zhao P; Xu Y; Ji W; Zhou S; Li L; Qiu L; Qian Z; Wang X; Zhang H
J Nanobiotechnology; 2021 Jun; 19(1):181. PubMed ID: 34120612
[TBL] [Abstract][Full Text] [Related]
31. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
Zhu H; Yang K; Yao H; Chen X; Yan S; He Y; Cao Y; Luo J; Wang D
Int J Nanomedicine; 2023; 18():3109-3124. PubMed ID: 37323948
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.
Zhang L; Yang P; Guo R; Sun J; Xie R; Yang W
Int J Nanomedicine; 2019; 14():8647-8663. PubMed ID: 31806962
[TBL] [Abstract][Full Text] [Related]
33. Combined Chemo-Immuno-Photothermal Therapy for Effective Cancer Treatment via an All-in-One and One-for-All Nanoplatform.
Yu X; Han N; Dong Z; Dang Y; Zhang Q; Hu W; Wang C; Du S; Lu Y
ACS Appl Mater Interfaces; 2022 Sep; 14(38):42988-43009. PubMed ID: 36109853
[TBL] [Abstract][Full Text] [Related]
34. NIR-II imaging-guided photothermal cancer therapy combined with enhanced immunogenic death.
Wang Y; Li W; Lin B; Yuan Y; Ning P; Tao X; Lv R
Biomater Sci; 2023 Jul; 11(15):5177-5185. PubMed ID: 37334508
[TBL] [Abstract][Full Text] [Related]
35. Phototherapy and anti-GITR antibody-based therapy synergistically reinvigorate immunogenic cell death and reject established cancers.
Sun Q; Yang Z; Lin M; Peng Y; Wang R; Du Y; Zhou Y; Li J; Qi X
Biomaterials; 2021 Feb; 269():120648. PubMed ID: 33445099
[TBL] [Abstract][Full Text] [Related]
36. Light-triggered OVA release based on CuS@poly(lactide-co-glycolide acid) nanoparticles for synergistic photothermal-immunotherapy of tumor.
Chen Z; Zhang Q; Zeng L; Zhang J; Liu Z; Zhang M; Zhang X; Xu H; Song H; Tao C
Pharmacol Res; 2020 Aug; 158():104902. PubMed ID: 32417504
[TBL] [Abstract][Full Text] [Related]
37. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
38. Polypyrrole-coated phase-change liquid perfluorocarbon nanoparticles for the visualized photothermal-chemotherapy of breast cancer.
Yang Q; Li P; Ran H; Wan J; Chen H; Chen H; Wang Z; Zhang L
Acta Biomater; 2019 May; 90():337-349. PubMed ID: 30936037
[TBL] [Abstract][Full Text] [Related]
39. Designing immunogenic nanotherapeutics for photothermal-triggered immunotherapy involving reprogramming immunosuppression and activating systemic antitumor responses.
Wang J; Chang Y; Luo H; Jiang W; Xu L; Chen T; Zhu X
Biomaterials; 2020 Oct; 255():120153. PubMed ID: 32540757
[TBL] [Abstract][Full Text] [Related]
40. Co-delivery of NIR-II semiconducting polymer and pH-sensitive doxorubicin-conjugated prodrug for photothermal/chemotherapy.
Yu D; Wang Y; Chen J; Liu S; Deng S; Liu C; McCulloch I; Yue W; Cheng D
Acta Biomater; 2022 Jan; 137():238-251. PubMed ID: 34653697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
